Analysys Of The Clinical Feature Of COPD Patients With Triple Therapy(ics/laba/lama)

被引：0
|
作者：
Miyazaki, M. [1 ]
Nakamura, H. [2 ]
Sasaki, M. [1 ]
Haraguchi, M. [1 ]
Chubachi, S. [1 ]
Takahashi, S. [1 ]
Yoshida, S. [3 ]
Shirahata, T. [4 ]
Asano, K. [5 ]
Betsuyaku, T. [1 ]
机构：
[1] Keio Univ, Tokyo, Japan
[2] Saitama Med Univ Hosp, Saitama, Japan
[3] Tokyo Med Ctr, Tokyo, Japan
[4] Saitama Social Insurance Hosp, Saitama, Japan
[5] Tokai Univ, Sch Med, Hiratsuka, Kanagawa, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4371
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
    Vanfleteren, Lowie
    Fabbri, Leonardo M.
    Papi, Alberto
    Petruzzelli, Stefano
    Celli, Bartolome
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3971 - 3981
  • [2] Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box
    Vanfleteren, Lowie E. G. W.
    Ullman, Anders
    Nordenson, Anita
    Andersson, Anders
    Andelid, Kristina
    Fabbri, Leonardo M.
    ERJ OPEN RESEARCH, 2019, 5 (01)
  • [3] Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
    Singh, Dave
    Fabbri, Leonardo M.
    Vezzoli, Stefano
    Petruzzelli, Stefano
    Papi, Alberto
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 531 - 546
  • [4] Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study
    Bogart, Michael
    Stanford, Richard H.
    Reinsch, Tyler
    Hull, Michael
    Buikema, Ami
    Hulbert, Erin
    RESPIRATORY MEDICINE, 2018, 142 : 73 - 80
  • [5] EVELUT®: dyspnoea and symptom burden in COPD patients switching from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Buhl, R.
    Dreher, M.
    Mattiucci-Guehlke, M.
    Eckhardt, S.
    Taube, C.
    Vogelmeier, C.
    Buhl, R.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [6] Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD
    Calzetta, Luigino
    Cazzola, Mario
    Matera, Maria Gabriella
    Rogliani, Paola
    CHEST, 2019, 155 (04) : 758 - 770
  • [7] Single Inhaler Triple-Therapy (ICS/LAMA/LABA) Versus Dual-Therapy (ICS/LABA or LAMA/LABA) in Patients with COPD at Risk of Exacerbations: Efficacy and Safety Results of the Phase III IMPACT Trial
    Lipson, D. A.
    Barnhart, F.
    Brealey, N.
    Day, N. C.
    Brooks, J.
    Criner, G.
    Dransfield, M. T.
    Halpin, D. M.
    Han, M. K.
    Jones, C.
    Kilbride, S.
    Lange, P.
    Lomas, D. A.
    Martinez, F. J.
    Singh, D.
    Tabberer, M.
    Wise, R. A.
    Pascoe, S. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [8] Population Pharmacokinetic Analysis of Single Inhaler Triple Therapy (ICS/LAMA/LABA) Versus Dual Therapy (LAMA/LABA and ICS/LABA) in Patients with Symptomatic COPD: Combined Results from Three Phase III Trials
    Mehta, R.
    Farrell, C.
    Kilbride, S.
    Zhu, C.
    Brooks, J.
    Barnhart, F.
    Birk, R.
    Lipson, D. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [9] Step up to ICS/LAMA/LABA vs switch to LAMA/LABA in patients with COPD on ICS/LABA: post hoc analysis of KRONOS
    Singh, Dave
    Bafadhel, Mona
    Bowen, Karin
    Arya, Niki
    Marshall, Jonathan
    Parikh, Himanshu
    Patel, Mehul
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] COMPARISON OF LAMA/LABA AND ICS/LABA AS INITIAL TREATMENT FOR COPD
    Aoyama, Junichi
    Tanaka, Yosuke
    Kosaihira, Seiji
    Okano, Tetuya
    Hino, Mitunori
    Seike, Masahiro
    Gemma, Akihiko
    RESPIROLOGY, 2019, 24 : 165 - 165
12345